ethylisopropylamiloride has been researched along with Peritoneal Carcinomatosis in 1 studies
ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hrgovic, I | 1 |
| Glavic, Z | 1 |
| Kovacic, Z | 1 |
| Mulic, S | 1 |
| Zunic, L | 1 |
| Hrgovic, Z | 1 |
1 other study available for ethylisopropylamiloride and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
Repeated administration of inhibitors for ion pumps reduce markedly tumor growth in vivo.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Amiloride; Animals; Cell Division; Cell Proliferat | 2014 |